Document:

Exhibit 10.4

 

Mota Group, Inc

 

MOTA GROUP, INC.

 

Subscription and Investor Rights Agreement

 

THIS SUBSCRIPTION AND
INVESTOR RIGHTS AGREEMENT is between the undersigned investor (the “Investor”) and MOTA GROUP, INC. (the “Company”).

 

WHEREAS, the Investor
desires to purchase from the Company and the Company desires to sell to the Investor a convertible promissory note (the “Note”)
on the terms and subject to the conditions set forth herein.

 

NOW, THEREFORE, the
Company and the Investor agree as follows:

 

1.          Subscription.
The Investor hereby agrees to purchase a Note in the aggregate principal amount set forth on the signature page. The Note has the
rights, preferences and privileges set forth in this Agreement and in form of Note, as attached as Appendix B to the Company’s
Summary of Terms for Convertible Note Financing (the “Offering Memorandum”), and which is to be filed by the
Company upon receipt of the minimum aggregate subscription amount, as such term is used in the Offering Memorandum.

 

THE INVESTOR UNDERSTANDS
THAT AN INVESTMENT IN THE NOTE INVOLVES A HIGH DEGREE OF RISK, AND THAT THE NOTE IS SUBJECT TO RESTRICTIONS ON TRANSFER AND RESALE.
THERE CAN BE NO ASSURANCES THAT THE INVESTOR WILL RECOVER ALL OR ANY PORTION OF THIS INVESTMENT.

 

2.          Execution
and Acceptance of Subscription and Investors Rights Agreement. Upon the execution hereof by the Investor and full payment of
the principal amount of the Note, subject to acceptance by the Company, the Company will issue to the Investor the Note subscribed
for by the Investor.

 

3.          Access
to Information; Independent Investigation. The Investor hereby acknowledges that:

 

a.           The
Investor has read this Subscription and Investor Rights Agreement and the Offering Memorandum (collectively, the “Investment
Documents”).

 

b.           In
making the decision to purchase the Note and the securities into which the Note is convertible, the Investor and the Investor’s
advisors have, prior to any sale to the Investor, been given the opportunity to examine all books and records of the Company and
all contracts and documents relating to the Company, as well as an opportunity to ask questions of, and to receive answers from,
the Company related to its business and this offering and to obtain any additional information necessary to verify the accuracy
of the information provided to the Investor. The Investor and the Investor’s advisors have been furnished with all materials
relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Note that
have been requested by the Investor.

 

    	Confidential Document – Authorized Personnel Only
	Page 1

     

    

 

Mota Group, Inc

 

c.           No
statements, promises, warranties or representations have been made to the Investor or the Investor’s advisors concerning
the Note of the securities into which the Note is convertible, the Company, its business or prospects, or other matters, by the
Company, the Company’s officers or employees, or any other person or entity, except as expressly set forth herein. The Investor
is not relying on any oral representation not otherwise contained in the Investment Documents in deciding to subscribe for the
Note.

 

4.          Investment
Representations. The Investor understands that the Note is being offered and sold in reliance upon certain exemptions from
the registration provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (the “Securities
Act”), and non-public offering exemptions of the securities laws of the states in which the Note may be offered or sold.
The Investor further represents and warrants as follows:

 

a.           Note
Not Registered; Indefinite Holding Period. The Investor has been advised that the Investor must be prepared to bear the economic
risk of an investment in the Company for an indefinite period because:

 

(i)          of
the nature of the Company’s operations and the risks involved;

 

(ii)         the
Note is not registered under applicable securities laws and regulations, and the Company does not intend that it be registered;
and

 

(iii)        the
securities into which the Note is convertible, when issued, will not be registered under applicable securities laws and regulations,
and the Company does not intend that it be registered.

 

b.           Illiquidity.
The Investor understands that there is not and will not be a market for the Note or the securities into which the Note is convertible
in the foreseeable future. The Company is not obligated to create or support a secondary market in its securities.

 

c.           Purchase
for Own Account. The Investor represents that the Note is being acquired, and the securities into which the Note is convertible
will be acquired, solely for the Investor’s own account for investment and not with a view toward, or for resale in connection
with, any “distribution” (as that term is used in the Securities Act) of all or any portion thereof.

 

d.           General
Solicitation. The Investor is not purchasing the Notes as a result of any advertisement, article, notice or other communication
regarding the Notes published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement.

 

e.           Further
Representations. The Investor further represents and warrants that:

 

(i)          The
Investor:

 

(A)         If
not an individual, is duly organized, validly existing and in good standing under the laws of its state of organization.

 

(B)         Has
full power to execute, deliver and perform this Subscription and Investor Rights Agreement.

 

    	Confidential Document – Authorized Personnel Only
	Page 2

     

    

 

Mota Group, Inc

 

(ii)         This
Subscription and Investor Rights Agreement has been duly executed and delivered by the Investor after receiving all required internal
and external approvals and constitutes a valid and binding obligation of the Investor, enforceable in accordance with its terms.

 

(iii)        The
execution of and performance of the transactions contemplated by this Subscription and Investor Rights Agreement and compliance
with its provisions by the Investor will not violate any provision of law by the Investor and will not conflict with or result
in any breach of any of the terms, conditions, or provisions of, or constitute a default under, or require a consent or waiver
under, any agreement or document to which the Investor is a party or otherwise bound, or any decree, judgment, order, statute,
rule or regulation applicable to the Investor.

 

(iv)        The
Investor is an “accredited investor” as defined in Rule 501(a) of Regulation D under
the Securities Act. The Investor was not formed for the specific purpose of acquiring the Note.

 

5.          Securities
Law Matters. The Investor agrees not to offer, sell, pledge, hypothecate or otherwise transfer or dispose of teh Note or the
securities into which the Note is convertible in the absence of an effective registration statement under the Securities Act covering
such disposition, or an opinion of counsel, satisfactory to the Company, to the effect that registration under the Securities Act
is not required in respect of such transfer or disposition.

 

6.          Representations
of the Company. At the time of the acceptance by the Company of this Subscription and Investor Rights Agreement, the Company
hereby represents and warrants to the Investor as follows:

 

a.           Organization.
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and
has all requisite corporate power and authority to own, lease and operate its properties, to carry on its business as presently
conducted and as proposed to be conducted and to carry out the transactions contemplated by this Subscription and Investors Rights
Agreement. A true, correct and complete copy of the Governance Document of the Company has been furnished to the Investor.

 

b.           Authorization.
All corporate action on the part of the Company, its officers, directors and shareholders necessary for the authorization, execution,
delivery and performance of this Subscription and Investor Rights Agreement and the consummation of the transactions contemplated
herein and therein has been taken. When executed and delivered by the Company, this Subscription and Investor Rights Agreement
shall constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its
terms, except as may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally
and by general equitable principles. The Company has all requisite corporate power to enter into this Subscription and Investor
Rights Agreement and to carry out and perform its obligations under the terms of this Subscription and Investor Rights Agreement.

 

c.           Valid
Issuance of the Note. The authorization, issuance, sale and delivery of the Note has been duly authorized by all requisite
corporate action of the Company.

 

    	Confidential Document – Authorized Personnel Only
	Page 3

     

    

 

Mota Group, Inc

 

d.           Consents.
All consents, approvals, orders and authorizations required on the part of the Company in connection with the execution, delivery
or performance of this Subscription and Investor Rights Agreement, and the consummation of the transactions contemplated herein
have been obtained, other than such filings required to be made after the closing under applicable federal and state securities
laws.

 

e.           No
Conflict. The execution and delivery of this Subscription and Investor Rights Agreement by the Company and the consummation
of the transactions contemplated hereby will not conflict with or result in any violation of or default (with or without notice
or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to
a loss of a material benefit under (i) any provision of the Governance Document or (ii) any agreement or instrument, permit, franchise,
license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Company or its properties or assets.

 

7.          Expenses.
The Investor and the Company shall each bear their own expenses incurred in connection with the negotiation and execution of this
Subscription and Investor Rights Agreement and the transactions contemplated hereby.

 

8.          Covenants
for the Benefit of the Investor. The Company agrees to the following covenants for the benefit of the Investor:

 

a.           Delivery
of Financial Statements and Other Information. The Company shall deliver to the Investor:

 

(i)          as
soon as practicable after the end of each fiscal year of the Company, financial statements for the year;

 

(ii)         as
soon as practicable, but in any event within thirty (30) days after the end of each fiscal quarter of the Company, a summary of
the principal cash expenditures for the quarter, together with a current equity capitalization table as of the end of such month
but only if there are material changes from the table most recently furnished; each such communication shall be accompanied by
a brief narrative relating to material developments in the business; and

 

(iii)        
such other information relating to the financial condition, business, prospects or corporate affairs of the Company the Investor
may from time to time reasonably request, provided, however, that the Company shall not be obligated under any circumstances
to (i) provide information which the Company reasonably deems in good faith to be a trade secret or similar confidential information
(unless covered by an enforceable confidentiality agreement, in form acceptable to the Company) or (ii) would adversely affect
the attorney-client privilege between the Company and its counsel.

 

b.           Confidentiality.
The Investor agrees that it will keep confidential and will not disclose or divulge any information obtained from the Company
that is and remains confidential.

 

c.           Expiration
of Covenants. The provisions of Sections 8 shall automatically expire upon the earlier of the following events: (i) the sale
of all or substantially all of the assets or business of the Company, by merger, sale of assets or otherwise; or (ii) the closing
of the Company’s first public offering of Common Stock on a firm commitment basis pursuant to an effective registration statement
under the Securities Act.

 

    	Confidential Document – Authorized Personnel Only
	Page 4

     

    

 

Mota Group, Inc

 

9.          Miscellaneous.

 

a.           Notices.
When any notice is required or authorized hereunder, such notice shall be given in writing and by personal delivery, Federal Express,
fax or email addressed to the party for which it is intended if to the Investor, to the address, fax number or email address of
the Investor set forth on the signature page hereto, as it may subsequently be changed on the Company’s books by notice from
the Investor; and if to the Company, to the address indicated as its principal executive offices on its website, attention: President.
A notice shall be deemed given on the date it is personally delivered or sent by fax or email or one business day after deposit
with Federal Express, specifying next business day delivery, with written verification of receipt.

 

b.           Successors
and Assigns. This Subscription and Investor Rights Agreement shall be binding upon the heirs, executors, administrators, successors,
and assignees of the Investor.

 

c.           Specific
Enforcement. Each party acknowledges and agrees that each party hereto will be irreparably damaged in the event any of the
provisions of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise breached.
Accordingly, it is agreed that each of the Company and the Investor shall be entitled to an injunction to prevent breaches of this
Agreement, and to specific enforcement of this Agreement and its terms and provisions in any action instituted in any court of
the United States or any state having subject matter jurisdiction.

 

d.           Remedies
Cumulative. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and
not alternative.

 

e.           Choice
of Law. This Subscription and Investor Rights Agreement shall be governed by, and construed in accordance with, the internal
laws of New York without regards to the choice of law provisions thereof and, to the extent it involves any United States statute
or regulations, in accordance therewith.

 

f.            Survival
of Representations. The Investor agrees that all of the warranties, representations, acknowledgments, confirmations, covenants
and promises made in this Subscription and Investor Rights Agreement shall survive its execution and delivery.

 

g.           Counterparts.
This Subscription and Investor Rights Agreement may be executed in any number of counterparts each of which shall be deemed an
original and which, taken together, shall form one and the same agreement. Execution and delivery of this Subscription and Investor
Rights Agreement may be evidenced by faxed or emailed signatures.

 

h.           Integration.
This Subscription and Investor Rights Agreement and such documents expressly referenced herein are the complete and exclusive agreement
between the parties with regard to the subject matter hereof and supersedes any and all prior discussions, negotiations and memoranda
related hereto.

 

    	Confidential Document – Authorized Personnel Only
	Page 5

     

    

 

Mota Group, Inc

 

i.            Amendment.
This Subscription and Investor Rights Agreement is one of a series of subscription and investor rights agreements entered into
by the company and certain other investors in connection with the transactions contemplated in the Offering Memorandum, and the
terms of this Subscription and Investor Rights Agreement may be amended or waived only by the joint consent of the Company and
the holders of a majority of the aggregate principal amount of Notes issued pursuant to the Offering Memorandum. Any amendment
or waiver effected in accordance with this Section shall be binding upon the Company, the holders of the Notes, and each permitted
transferee of the Notes.

 

	 	MOTA GROUP, INC.	 
	 	 	 	 
	 	By:  	 	 
	 	 	Michael Faro, President	 

 

[Investor signature page follows.]

 

    	Confidential Document – Authorized Personnel Only
	Page 6

     

    

 

Mota Group, Inc

 

MOTA®

MOTA GROUP, INC.

Investor Signature Page to

Subscription and Investors Rights Agreement

 

The Investor hereby
executes this Subscription and Investor Rights Agreement. By executing this signature page, the Investor attests and swears, under
the pains and penalties of perjury, that (initial all that apply) the Investor is:

 

	1.          ACCREDITATION STATUS 
	 ̈	A corporation, a business trust, or a partnership, not formed for the specific purpose of acquiring the Notes, with total assets in excess of $5,000,000.
	 ̈	A natural person whose net worth, or joint net worth with my spouse, exceeds $1,000,000 (net worth being defined as the excess of (a) my total assets (excluding the estimated fair market value of my primary residence) over (b) my total liabilities (excluding indebtedness secured by my primary residence up to the fair market value of such residence, but including (i) any indebtedness secured by my primary residence in excess of the residence’s fair market value and (ii) any indebtedness (or increase in pre-existing indebtedness) secured by such residence incurred within 60 days of the purchase date of the Notes other than as a result of the acquisition of such residence).
	 ̈	A natural person who had an individual income in excess of $200,000 in each of the two most recent years, or joint income with his or her spouse in excess of $300,000 in each of those years, and has a reasonable expectation of reaching the same income level in the current year.
	 ̈	A trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Notes.
	 ̈	An entity in which all of the equity owners fall within one of the categories set forth above.

 

2.          INVESTMENT
INFORMATION

 

	Aggregate Principal Amount of Notes purchased:	 	 

 

3.          INVESTOR
INFORMATION

 

	Name of Investor:	 	Social Security/Tax ID:	 
	 	 	 	 
	Email Address:	 	Fax Number:	 
	 	 	 	 
	Street Address:	 
	 	 	 	 
	Mailing Address (If different)	 

 

4.          SIGNATURE

 

ACCEPTED AND AGREED

 

	INVESTOR	 	 	COMPANY
	 	 	 	 
	BY: 	 	 	 	BY: 	 
	 	 	 	 
	NAME/TITLE:  	 	 	 	 	NAME:  Michael Faro
	 	 	 	 	TITLE: President
	DATE: 	 	 	 	 
	 	 	 	DATE: 	 

 

    	Confidential Document – Authorized Personnel Only
	Page 7Exhibit 10.5

 

CONFIDENTIAL DOCUMENT

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

 

THIS
NOTE AND THE REDEMPTION CONVERSION SHARES OR QUALIFIED TRANSACTION SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE REDEMPTION CONVERSION
SHARES OR QUALIFIED TRANSACTION SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT AND ANY APPLICABLE
STATE SECURITIES LAWS OR (B) AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.

 

CONVERTIBLE TERM NOTE

 

FOR VALUE RECEIVED, MOTA
GROUP, INC., a Delaware corporation (the “Company”), hereby promises to pay to ________________________, with an address
at _____________________________ _________________________________________________ (the “Holder”) or its registered
assigns or successors in interest, an aggregate of __________________________ ($______________) (the “Principal Amount”),
together with any accrued and unpaid interest hereon, on [24 months from issuance], or otherwise sooner payable as provided herein
(the “Maturity Date”), if not sooner indefeasibly paid in full or converted as provided herein.

 

This Convertible Term
Note (this “Note”) has been issued pursuant to that certain Subscription and Investor Rights Agreement (including the
exhibits and schedules thereto), dated as of even date herewith (as amended, restated, modified and/or supplemented from time to
time, the “Purchase Agreement”), between the Company and the Holder. Capitalized terms used herein and not otherwise
defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement.

 

ARTICLE
I

CONTRACT RATE AND
AMORTIZATION

 

1.1          Contract
Rate. Subject to Section 3.2, interest payable on the outstanding principal amount
of this Note shall accrue at a rate per annum equal to eight percent (8%) (the “Contract Rate”). Accrued and unpaid
interest shall be payable on the Maturity Date. Interest on this Note shall accrue from the date of issuance until repayment of
the Principal Amount and payment of all accrued interest in full. Interest shall accrue and be computed on the basis of the actual
number of days in the related period over 360 days.

 

1.2          The
obligations to make the payments provided for in this Note are absolute and unconditional and not subject to any defense, set-off,
counterclaim, rescission, recoupment or adjustment whatsoever. The Company hereby expressly waives demand and presentment for payment,
notice of non-payment, notice of dishonor, protest, notice of protest and diligence in taking any action to collect any amount
called for hereunder, and shall be directly and primarily liable for the payment of all sums owing and to be owing hereon, regardless
of and without any notice, diligence, act or omission with respect to the collection of any amount called for hereunder.

 

     

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

ARTICLE
II

HOLDER’S CONVERSION
RIGHTS

 

2.1          Automatic
Conversion. In the event that the Company issues securities in a Subsequent Financing (as defined below) this Note shall automatically
convert into and become the right to receive the same securities of the Company issued in the Subsequent Financing (the “Restricted
Securities”) in an amount equal to (i) one hundred percent (100%) of the Principal Amount outstanding at such time together
with accrued but unpaid interest thereon and any and all other sums due, accrued or payable to the Holder arising under this Note,
divided by (ii) (a) the offering price per security in the Subsequent Financing, multiplied by (b) [1-the discount expressed as
a decimal]. The term “Subsequent Financing” means any offering by the Company of its common stock, Common Stock Equivalents
(as defined below) or any combination thereof resulting in gross proceeds of not less than $5,000,000. The term “Common Stock
Equivalents” means any securities of the Company which would entitle the holder thereof to acquire, at any time, shares of
the Company’s common stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares
of the Company’s common stock.

 

2.2          Mechanics
of Conversion. Immediately subsequent to the closing of the Subsequent Financing, the Company shall give notice of such event
to the Holder and indicate to the Holder the number of Restricted Shares issuable pursuant to the conversion of this Note, instructions
for surrendering the Note, and requesting information on where to send the Restricted Shares pursuant to Section 2.1. Within five
(5) business days of the surrender of the Note in accordance with the Company’s instructions and the receipt of instructions
as to the delivery of the Restricted Shares, as applicable, by the Company, the Company shall issue the Restricted Shares to the
Holder. The Holder shall be treated for all purposes as the record holder of the Restricted Shares unless the Holder provides the
Company written instructions to the contrary.

 

2.3          Rights
of Shareholders. No Holder shall be entitled to vote or receive dividends or be deemed the holder of the Company’s securities
which may at any time be issuable upon conversion of this Note for any purpose, nor shall anything contained herein be construed
to confer upon the Holder, as such, any of the rights of a shareholder of the Company or any right to vote for the election of
directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate
action (whether upon the recapitalization, issuance of shares, reclassification of shares, change of nominal value, consolidation,
merger, conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise,
in each case, until the applicable date of conversion.

 

    	 	2	 

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

ARTICLE
III

EVENTS OF DEFAULT

 

3.1          Events
of Default. The occurrence of any of the following events set forth in this Section 3.1 shall constitute an event of
default (“Event of Default”) hereunder:

 

(a)          Failure
to Pay. The Company shall fail to pay, within five (5) days of when due, any installment of principal, interest or other fees
hereon in accordance herewith and, in any such case, such failure shall continue for a period of ten (10) days following the date
upon which any such payment was due;

 

(b)          Breach
of Covenant. The Company shall breach any covenant or any other term or condition of this Note and such breach, if subject
to cure, continues for a period of fifteen (15) days after the occurrence thereof, provided, however, that if such
breach cannot be reasonably cured within fifteen (15) days, such cure period shall be extended so long as the Company is diligently
and continuously seeking a cure of such breach, but, in any event, such additional period of time shall not exceed ninety (90)
days;

 

(c)          Breach
of Representations and Warranties. Any representation, warranty or statement made or furnished by the Company in this Note
or the Purchase Agreement shall at any time be false or misleading in any material respect on the date as of which made or deemed
made;

 

(d)          Bankruptcy.
The Company shall (i) apply for, consent to or suffer to exist the appointment of, or the taking of possession by, a receiver,
custodian, trustee or liquidator of itself or of all or a substantial part of its property, (ii) make a general assignment for
the benefit of creditors, (iii) commence a voluntary case under the federal bankruptcy laws (as now or hereafter in effect), (iv)
be adjudicated a bankrupt or insolvent, (v) file a petition seeking to take advantage of any other law providing for the relief
of debtors, (vi) acquiesce to, without challenge within ten (10) days of the filing thereof, or failure to have dismissed, within
sixty (60) days, any petition filed against it in any involuntary case under such bankruptcy laws, or (vii) take any action for
the purpose of effecting any of the foregoing;

 

(e)          Insolvency.
The Company shall admit in writing its inability, or be generally unable, to pay its debts as they become due or cease operations
of its present business;

 

(f)          Change
of Control. Except in connection with a Subsequent Financing, any person that does not currently own in excess of 30% of the
voting power of the Company acquiring in excess of 30% of the voting power of the Company; or

 

    	 	3	 

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

(g)          The
Purchase Agreement. (i) The Company shall breach any covenant or term or provision of the Purchase Agreement in any material
respect and such breach, if capable of cure, continues unremedied for a period of fifteen (15) days after the occurrence thereof,
provided, however, that if such breach cannot be reasonably cured within fifteen (15) days, such cure period shall
be extended so long as the Company is diligently and continuously seeking a cure of such breach, but, in any event, such additional
period of time shall not exceed ninety (90) days, (ii) the Company attempts to terminate, challenge the validity of, or its liability
under, the Purchase Agreement, (iii) any proceeding shall be brought to challenge the validity, binding effect of the Purchase
Agreement, or (iv) the Purchase Agreement ceases to be a valid, binding and enforceable obligation of the Company. 

 

3.2          Remedies;
Default Interest. Upon the occurrence and during the continuation of any Event of Default, in addition to any other remedies
set forth herein or allowed by law, the unpaid principal amount of this Note, any accrued and unpaid interest and all other amounts
payable hereunder or under the Purchase Agreement may be declared by the Holder at its election to be immediately due and payable,
whereupon such acceleration the unpaid principal amount of this Note, any accrued and unpaid interest and all such other amounts
shall become immediately due and payable without presentment, demand, protest or further notice of any kind. The Holder shall have
all rights and may exercise any remedies available to it hereunder or under law, successively or concurrently. Following the occurrence
and during the continuance of an Event of Default and without any action required on the part of the Holder, the Company shall
pay interest on the outstanding principal balance of this Note in an amount equal to eighteen percent (18%) per annum, and all
outstanding obligations under this Note and the Purchase Agreement, including unpaid interest, shall continue to accrue interest
at such interest rate from the date of such Event of Default until the date such Event of Default is cured or waived.

 

ARTICLE
IV

MISCELLANEOUS

 

4.1          Cumulative
Remedies. The remedies under this Note shall be cumulative.

 

4.2          Failure
or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other
or further exercise thereof or of any other right, power or privilege. All rights and remedies existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available. No course of dealing between the Company and the Holder shall
operate as a waiver of any such right or remedy of the Holder.

 

4.3          Notices.
Any notice herein required or permitted to be given shall be given in writing in accordance with the terms of the Purchase Agreement.

 

4.4          Amendment
Provision. This Note may only be amended by an instrument in writing signed by each of the Company and the Holder. The term
“Note” and all references thereto, as used throughout this instrument, shall mean this instrument as originally executed,
or if later amended or supplemented, then as so amended or supplemented, and any successor instrument as such successor instrument
may be amended or supplemented.

 

    	 	4	 

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

4.5          Assignability.
This Note shall be binding upon the Company and its successors and assigns, and shall inure to the benefit of the Holder and its
successors and assigns, and may be assigned by the Holder in accordance with the requirements of the Purchase Agreement. The Company
may not assign any of its obligations under this Note without the prior written consent of the Holder, any such purported assignment
without such consent being null and void. Notwithstanding any document, instrument or agreement relating to this Note to the contrary,
transfer of this Note (or the right to any payments of principal or stated interest thereunder) may only be effected by surrender
of this Note and either the reissuance by the Company of this Note to the new holder or the issuance by the Company of a new instrument
to the new holder.

 

4.6          Cost
of Collection. In case of the occurrence of an Event of Default under this Note, the Company shall pay the Holder the Holder’s
reasonable costs of collection, including reasonable attorneys’ fees.

 

4.7          Governing
Law, Jurisdiction and Waiver of Jury Trial.

 

(a)          THIS
NOTE SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES
OF CONFLICTS OF LAW.

 

(b)          THE
COMPANY HEREBY CONSENTS AND AGREES THAT THE STATE AND/OR FEDERAL COURTS LOCATED IN THE COUNTY OF NEW YORK, STATE OF NEW YORK SHALL
HAVE EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN THE COMPANY, ON THE ONE HAND, AND THE HOLDER AND/OR
ANY OTHER CREDITOR PARTY, ON THE OTHER HAND, PERTAINING TO THIS NOTE OR THE PURCHASE AGREEMENT OR TO ANY MATTER ARISING OUT OF
OR RELATED TO THIS NOTE OR THE PURCHASE AGREEMENT; PROVIDED, THAT THE COMPANY ACKNOWLEDGES THAT ANY APPEALS FROM THOSE COURTS
MAY HAVE TO BE HEARD BY A COURT LOCATED OUTSIDE OF THE COUNTY OF NEW YORK, STATE OF NEW YORK; AND FURTHER PROVIDED,
THAT NOTHING IN THIS NOTE SHALL BE DEEMED OR OPERATE TO PRECLUDE THE HOLDER AND/OR ANY OTHER CREDITOR PARTY FROM BRINGING SUIT
OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION TO COLLECT THE AMOUNT DUE HEREUNDER. THE COMPANY EXPRESSLY SUBMITS AND CONSENTS
IN ADVANCE TO SUCH JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND THE COMPANY HEREBY WAIVES ANY OBJECTION
WHICH IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS. THE COMPANY HEREBY WAIVES
PERSONAL SERVICE OF THE SUMMONS, COMPLAINT AND OTHER PROCESS ISSUED IN ANY SUCH ACTION OR SUIT AND AGREES THAT SERVICE OF SUCH
SUMMONS, COMPLAINT AND OTHER PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL ADDRESSED TO THE COMPANY AT THE ADDRESS SET FORTH
IN THE PURCHASE AGREEMENT AND THAT SERVICE SO MADE SHALL BE DEEMED COMPLETED UPON THE EARLIER OF THE COMPANY’S ACTUAL RECEIPT
THEREOF OR THREE (3) DAYS AFTER DEPOSIT IN THE U.S. MAILS, PROPER POSTAGE PREPAID.

 

    	 	5	 

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

(c)          THE
PARTIES HERETO DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST
COMBINATION OF THE BENEFITS OF THE JUDICIAL SYSTEM AND/OR OF ARBITRATION, THE COMPANY WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY
ACTION, SUIT, OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER ARISING IN CONTRACT, TORT, OR OTHERWISE BETWEEN THE HOLDER
AND/OR ANY OTHER CREDITOR PARTY, ON THE ONE HAND, AND THE COMPANY, ON THE OTHER HAND, ARISING OUT OF, CONNECTED WITH, RELATED OR
INCIDENTAL TO THE RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION WITH THIS NOTE, ANY OTHER TRANSACTION DOCUMENT OR THE TRANSACTIONS
RELATED HERETO OR THERETO.

 

4.8          Severability.
In the event that any provision of this Note is invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with
such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity
or enforceability of any other provision of this Note.

 

4.9          Maximum
Payments. Nothing contained herein shall be deemed to establish or require the payment of a rate of interest or other charges
in excess of the maximum permitted by applicable law. In the event that the rate of interest required to be paid or other charges
hereunder exceed the maximum rate permitted by such law, any payments in excess of such maximum rate shall be credited against
amounts owed by the Company to the Holder and thus refunded to the Company.

 

4.10        Construction;
Counterparts. Each party acknowledges that its legal counsel participated in the preparation of this Note and, therefore, stipulates
that the rule of construction that ambiguities are to be resolved against the drafting party shall not be applied in the interpretation
of this Note to favor any party against the other. This Note may be executed by the parties hereto in one or more counterparts,
each of which shall be deemed an original and all of which when taken together shall constitute one and the same instrument. Any
signature delivered by a party by facsimile or electronic transmission shall be deemed to be an original signature hereto.

 

4.11        Loss.
Upon receipt of evidence reasonably satisfactory to the Company, of the loss, theft, destruction or mutilation of this Note (and
upon surrender of this Note if mutilated), including an affidavit of the Holder thereof that this Note has been lost, stolen, destroyed
or mutilated together with an indemnity against any claim that may be made against the Company on account of such lost, stolen,
destroyed or mutilated Note, the Company shall execute and deliver to the Holder a new Note of like date, tenor and denomination.

 

    	 	6	 

     

    

 

		CONVERTIBLE NOTE TERMS - APPENDIX B

 

IN WITNESS WHEREOF, the
Company has caused this Convertible Term Note to be signed in its name effective as of this _____ day of _______, 2016.

 

	 	MOTA GROUP, INC.
	 	 	 
	 	By: 	 
	 	 
	 	Name: 
	 	 
	 	Title:

 

    	 	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]